Robin Lachapelle serves as Executive at ArriVent BioPharma, Inc., where they oversee executive responsibilities. Since joining the company, Robin Lachapelle has executed 9 insider transactions totaling $0, demonstrating a balanced approach to their equity position. Their most recent transaction on Feb 2, 2026 involved receiving (via award) 130,000 shares valued at $0.
Robin Lachapelle currently holds 130,000 shares of ArriVent BioPharma, Inc. (AVBP), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Robin Lachapelle has been a net neutral trader of AVBP stock. They have purchased $0 and sold $0 worth of shares.
Robin Lachapelle's most recent insider trade was on Feb 2, 2026, when they sold 130,000 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $2.28 |
| Discretionary |
| Jul 11, 2025 | AVBP | $14.8K | Option Exercise | 6,503 | $2.28 | Discretionary |
| Jul 11, 2025 | AVBP | $4.7K | Option Exercise | 2,050 | $2.28 | Discretionary |
| Sep 19, 2024 | AVBP | $6.5K | Option Exercise | 2,867 | $2.28 | Discretionary |
| Sep 19, 2024 | AVBP | $16.8K | Option Exercise | 2,700 | $6.24 | Discretionary |
| Sep 19, 2024 | AVBP | $16.3K | Option Exercise | 7,164 | $2.28 | Discretionary |
| Sep 19, 2024 | AVBP | $45.1K | Option Exercise | 12,364 | $3.65 | Discretionary |
| Sep 19, 2024 | AVBP | $5.6K | Option Exercise | 2,471 | $2.28 | Discretionary |